Clinical efficacy and language recovery of butylphthalide injection in aphasia patients with cerebral infarction

doi:10.3969/j.issn.1004-583X.2016.02.012

Abstract

Abstract: Objective To study the clinical efficacy of butylphthalide injection and the language recovery in aphasia patients with cerebral infarction.Methods Twenty-six aphasia patients with acute cerebral infarction were randomly divided into two groups, treatment and control. Both groups were treated with anti-platelet and basic therapy conventionally, but the treatment group was treated with butylphthalide injection, 100 ml, intravenously, 1/12 h for (11± 3) d. NIHSS and AQ were recorded before and after treatment.Results Before treatment,the gender, age, onset time, NIHSS score and complications of the patients,such as hypertension, diabetes, hyperlipidemia in two groups had no significant difference (P>0.05). After treatment, the scores of NIHSS decreased in two groups (P＜0.01). However, the score of treatment group decreased significantly compared with that of control group (P＜0.05). The clinical efficacy and the improvement of AQ were significantly better than those of control group (P<0.05).Conclusion Butylphthalide injection in the treatment of aphasia patients with cerebral infarction can improve the clinical function effectively and promote the recovery of language function injury at the same time, it also has a high security in clinical application.

Key words: brain infarction, aphasia, butylphthalide injection

CLC Number:

R743.33

Wu Xiaona, Liu Yan, Xiang Wei, Xiong Tiegen, Li Chunyong,Deng Wenting. Clinical efficacy and language recovery of butylphthalide injection in aphasia patients with cerebral infarction[J]. Clinical Focus, 2016, 31(2): 187-190.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.02.012

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I2/187

References

[1] Donnan GA, Fisher M, Macleod M, et al. Stroke[J]. Lancet, 2008, 371(9624):1612-1623.
[2] 常静玲,高颖.“形神合一”理论指导下的脑卒中后失语康复治疗与评价[J].中华中医药杂志,2013,28(9):2523.
[3] 姚东陂,张锦丽,王红欣.脑梗死的治疗现状及研究进展[J].解放军医药杂志,2012,24(12):55-59.
[4] 李淑敏,范铁平,王翠.丁苯酞治疗急性脑梗死的疗效观察[J].中国实用神经疾病杂志,2009,12(8):24-25.
[5] 王宝亮,钱百成.丁苯酞软胶囊治疗急性脑梗死30例临床疗效观察[J].中国当代医药,2009,16(24):65-66.
[6] 王静,李玲,马瑞莲. 丁苯酞注射液治疗急性脑梗死疗效观察[J]. 宁夏医科大学学报,2013,34(12):1325-1326.
[7] 王新德.各类脑血管疾病诊断要点[J].中华神经科杂志,1996, 29(6):379-380.
[8] 王文敏.丁苯酞联合银杏达莫治疗急性脑梗死的疗效观察[J]. 河北医药, 2013,35(11):1702-1703.
[9] 王拥军.卒中单元[M].北京:科学技术文献出版社,2003:310.
[10] Tennant A,Geddes JM,Fear J,et al. Outcome following stroke[J]. Dis Rehab, 1997, 19(7):278-284.
[11] Berthier ML. Poststroke aphasia: epidemiology pathophysiology and treatment[J].Drugs Aging, 2005, 22(2):163 -182.
[12] 王琦, 杨森, 王虎,等. 高压氧联合美多巴治疗卒中后失语疗效观察[J].中国实用神经疾病杂志, 2010,13(4):9-11.
[13] 吴睿. 灯盏细辛联合重复经颅磁刺激治疗脑梗死后失语症的疗效观察. 中国实用神经疾病杂志, 2008,11(9):64-65.
[14] 张成宗. 多奈哌齐联合针刺及语言康复措施治疗脑梗死后失语的临床分析[J].中国医药科学,2015,5(3):94-96.
[15] 李鹏,段莉.补阳还五汤联合多奈哌齐治疗急性脑卒中后失语临床观察[J]. 中国中医急症, 2013, 22(2):298-300.
[16] 种兆忠, 冯亦璞.丁基苯酞对缺血脑组织中及低糖低氧刺激后培养的神经细胞中胆碱乙酰化酶活性的影响[J].中国药学杂志,1999, 34(8): 519-522.
[17] 冯亦璞, 胡盾, 张丽英.丁基苯酞对小鼠全脑缺血的保护作用[J].药学学报,1995,30(10):741-744.
[18] 崔丽英,李舜伟,张微微,等. dl-3- 正丁基苯酞软胶囊与阿司匹林治疗急性缺血性脑卒中的多中心、随机、双盲双模拟对照研究[J]. 中华神经科杂志, 2008, 41(11): 727-730.
[19] 徐蓓,赵志刚. 脑血管病治疗药物丁苯酞注射液的药理与临床研究评价[J]. 中国新药杂志,2011,20(11):947-950.
[20] Liao SJ,Lin JW, Pei Z,et al.Enhanced angiogenesis with dl-3n-butylphthalide treatment after focal cerebral ischemia in RHRSP[J].Brain Res,2009,1289:69-78.
[21] Li L, Zhang B, Tao Y,et al. DL-3-n-butylphthalide protects endothelial cells against oxidative/nitrosative stress,mitochondrial damage and subsequent cell death after oxygen glucose deprivation in vitro[J]. Brain Res,2009,1290:91-101.
[22] 董高翔,冯亦璞.丁基苯酞对局部脑缺血再灌注大鼠脑线粒体 ATPase,抗氧化酶活性脂脂质过氧化的影响[J].中国医学科学院学报,2002,24(1):93-97.
[23] 刘昌云,陈枝挺,黄华品. 丁苯酞注射液对急性脑梗死患者血清NO和NOS表达及临床疗效的影响[J]. 中国老年学杂志, 2013, 33(14): 3448-3449.
[24] 李强,郭宗成,张和振,等.丁苯酞注射液对慢性脑缺血大鼠MDA、SOD的影响[J].脑与神经疾病杂志,2008, 16(4):521-522.